Best TWAS P=1.15e-44 · Best GWAS P=6.88e-39 conditioned to 0.668
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | ADCY3 | 0.16 | 0.12 | lasso | 10 | 0.14 | 3.2e-17 | 12.8 | -14.0 | 1.1e-44 | -0.89 | 0.01 | 0.99 | TRUE |
2 | CommonMind | Brain Pre-frontal Cortex | CENPO | 0.07 | 0.03 | bslmm | 322 | 0.03 | 7.0e-05 | 8.0 | -10.8 | 3.0e-27 | -0.49 | 0.48 | 0.25 | FALSE |
3 | GTEx | Adipose Subcutaneous | ADCY3 | 0.07 | 0.04 | lasso | 6 | 0.01 | 3.2e-02 | 12.1 | 11.9 | 7.1e-33 | 0.87 | 0.07 | 0.92 | FALSE |
4 | GTEx | Adipose Subcutaneous | RP11-443B20.1 | 0.04 | 0.00 | enet | 10 | 0.00 | 1.2e-01 | 7.6 | 10.7 | 1.2e-26 | 0.82 | 0.04 | 0.90 | FALSE |
5 | GTEx | Adrenal Gland | PTRHD1 | 0.32 | 0.28 | lasso | 3 | 0.26 | 8.3e-10 | -6.8 | 7.3 | 3.6e-13 | 0.41 | 0.98 | 0.00 | FALSE |
6 | GTEx | Artery Tibial | ADCY3 | 0.21 | 0.14 | lasso | 6 | 0.15 | 4.3e-12 | 11.0 | 12.5 | 6.4e-36 | 0.70 | 0.98 | 0.02 | FALSE |
7 | GTEx | Artery Tibial | RP11-443B20.1 | 0.17 | 0.08 | enet | 40 | 0.09 | 8.2e-08 | 11.0 | 11.0 | 3.8e-28 | 0.59 | 0.48 | 0.48 | FALSE |
8 | GTEx | Cells EBV-transformed lymphocytes | ADCY3 | 0.25 | 0.23 | enet | 10 | 0.12 | 9.2e-05 | 12.1 | -10.6 | 2.9e-26 | -0.84 | 0.02 | 0.97 | FALSE |
9 | GTEx | Cells EBV-transformed lymphocytes | RP11-443B20.1 | 0.13 | 0.13 | enet | 9 | 0.05 | 9.2e-03 | 12.1 | -12.5 | 5.0e-36 | -0.93 | 0.01 | 0.96 | FALSE |
10 | GTEx | Esophagus Muscularis | NCOA1 | 0.11 | 0.01 | enet | 9 | 0.01 | 5.8e-02 | 2.5 | 5.6 | 1.9e-08 | 0.45 | 0.08 | 0.13 | FALSE |
11 | GTEx | Nerve Tibial | ADCY3 | 0.09 | 0.05 | enet | 6 | 0.03 | 2.2e-03 | 11.0 | -13.5 | 1.8e-41 | -0.92 | 0.01 | 0.99 | FALSE |
12 | GTEx | Nerve Tibial | RP11-443B20.1 | 0.07 | 0.03 | enet | 6 | 0.02 | 1.1e-02 | 11.0 | -12.9 | 8.0e-38 | -0.82 | 0.02 | 0.97 | FALSE |
13 | GTEx | Whole Blood | DNAJC27 | 0.08 | 0.10 | lasso | 1 | 0.10 | 2.2e-09 | 11.8 | 11.8 | 3.6e-32 | 0.80 | 0.77 | 0.23 | FALSE |
14 | GTEx | Whole Blood | ADCY3 | 0.23 | 0.24 | enet | 24 | 0.27 | 5.5e-25 | 12.4 | 13.3 | 1.8e-40 | 0.87 | 0.72 | 0.28 | FALSE |
15 | GTEx | Whole Blood | RP11-443B20.1 | 0.21 | 0.17 | enet | 32 | 0.20 | 1.8e-18 | 11.8 | 13.6 | 5.3e-42 | 0.87 | 0.66 | 0.34 | FALSE |
16 | METSIM | Adipose | EFR3B | 0.04 | 0.00 | bslmm | 357 | 0.00 | 9.7e-02 | -1.5 | -7.2 | 5.7e-13 | -0.37 | 0.06 | 0.08 | FALSE |
17 | ROSMAP | Brain Pre-frontal Cortex | ADCY3 | 0.17 | 0.26 | enet | 32 | 0.26 | 6.8e-33 | 12.4 | -13.4 | 8.6e-41 | -0.90 | 0.64 | 0.36 | FALSE |
18 | ROSMAP | Brain Pre-frontal Cortex | CENPO | 0.08 | 0.04 | enet | 5 | 0.05 | 2.6e-07 | -4.8 | -6.1 | 8.5e-10 | -0.36 | 1.00 | 0.00 | FALSE |
19 | YFS | Blood | ADCY3 | 0.07 | 0.02 | bslmm | 343 | 0.04 | 7.3e-14 | 13.0 | -7.3 | 2.4e-13 | -0.63 | 0.00 | 1.00 | FALSE |
20 | YFS | Blood | POMC | 0.35 | 0.05 | enet | 71 | 0.19 | 5.7e-59 | -8.9 | -7.4 | 1.6e-13 | -0.30 | 1.00 | 0.00 | TRUE |
21 | The Cancer Genome Atlas | Breast Invasive Carcinoma | ADCY3 | 0.05 | 0.03 | blup | 81 | 0.03 | 5.0e-07 | 1.6 | -6.8 | 8.8e-12 | -0.51 | 0.57 | 0.38 | FALSE |
22 | The Cancer Genome Atlas | Breast Invasive Carcinoma | POMC | 0.08 | 0.05 | lasso | 3 | 0.06 | 2.6e-12 | -1.4 | -6.0 | 2.2e-09 | -0.20 | 0.97 | 0.03 | FALSE |
23 | The Cancer Genome Atlas | Glioblastoma Multiforme | C2orf84 | 0.13 | 0.07 | blup | 56 | 0.05 | 1.5e-02 | 5.0 | 5.3 | 9.4e-08 | 0.10 | 0.02 | 0.14 | TRUE |
24 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | POMC | 0.06 | 0.00 | enet | 12 | 0.03 | 9.3e-05 | -1.4 | -6.6 | 4.6e-11 | -0.26 | 0.01 | 0.41 | FALSE |
25 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | EFR3B | 0.03 | 0.05 | lasso | 1 | 0.04 | 1.9e-05 | -10.1 | -10.1 | 6.1e-24 | -0.65 | 0.56 | 0.06 | FALSE |
26 | The Cancer Genome Atlas | Brain Lower Grade Glioma | ADCY3 | 0.03 | 0.02 | blup | 81 | 0.02 | 7.1e-04 | 8.4 | -11.6 | 3.2e-31 | -0.88 | 0.03 | 0.94 | FALSE |
27 | The Cancer Genome Atlas | Lung Adenocarcinoma | DNAJC27 | 0.05 | 0.01 | blup | 46 | 0.04 | 3.2e-05 | 2.8 | -6.4 | 1.8e-10 | -0.56 | 0.36 | 0.59 | FALSE |
28 | The Cancer Genome Atlas | Lung Adenocarcinoma | NCOA1 | 0.02 | 0.01 | blup | 77 | 0.01 | 1.2e-02 | -4.2 | -5.2 | 2.1e-07 | -0.23 | 0.11 | 0.07 | FALSE |
29 | The Cancer Genome Atlas | Lung Adenocarcinoma | POMC | 0.14 | 0.04 | enet | 7 | 0.08 | 5.3e-10 | -1.4 | -6.8 | 9.3e-12 | -0.21 | 0.37 | 0.62 | FALSE |
30 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | POMC | 0.19 | 0.01 | blup | 38 | 0.05 | 1.5e-04 | -8.9 | -7.1 | 1.1e-12 | -0.32 | 0.01 | 0.57 | FALSE |
31 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | POMC | 0.22 | 0.05 | blup | 37 | 0.03 | 2.1e-02 | -1.9 | -5.8 | 7.4e-09 | -0.11 | 0.01 | 0.29 | FALSE |
32 | The Cancer Genome Atlas | Prostate Adenocarcinoma | POMC | 0.11 | 0.08 | enet | 7 | 0.09 | 1.6e-09 | -1.4 | -6.8 | 1.3e-11 | -0.23 | 0.87 | 0.12 | FALSE |